Indeed, critical and breast cancer subtype-specific relationships are known to exist between proliferation and inflammation in cancer, often involving NFκB that controls the balance between a more aggressive metastasis-promoting state and a more quiescent and controlled cancer state [37]. Here, NFKB1 is linked to breast carcinoma.